Literature DB >> 25541640

Neurologically-related sequelae associated with mild traumatic brain injury.

Timothy S Webb1, Casserly R Whitehead, Timothy S Wells, Russell K Gore, Clifford N Otte.   

Abstract

OBJECTIVE: Mild traumatic brain injury (mTBI) accounts for more than 75% of traumatic brain injuries every year. This study examines the temporal association between non-blast mTBI and the onset of neurologic sequelae to illuminate risks of post-concussive syndrome, epilepsy and chronic pain.
METHODS: A large historical prospective study was conducted utilizing electronically-recorded demographic, medical and military-specific data for over half a million active duty US Air Force Airmen. This study utilized diagnostic codes to identify mTBI exposures, two control groups and three post-mTBI time periods. Adjusted hazard ratios (HRs) were calculated using Cox proportional hazards modelling.
RESULTS: HRs were higher when mTBI exposed Airmen were compared with the full cohort and lower when compared with the other injured group. When compared to the other injured group, mTBI was positively associated with epilepsy/recurrent seizure outcomes, post-concussive syndrome and pain disorders. HRs tended to be highest within the first 30 days and decreased over time.
CONCLUSIONS: Findings support that mTBI may have a prolonged neurological impact. Findings are also likely generalizable to young adult populations with exposure to non-blast related mTBI, including civilians, as those included in this study were young adults with a high prevalence of recreational/sports and motor vehicle injuries.

Entities:  

Keywords:  Concussion; mild brain injury; neurological; post-concussional syndrome.

Mesh:

Year:  2014        PMID: 25541640     DOI: 10.3109/02699052.2014.989904

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  6 in total

Review 1.  Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder.

Authors:  Kaitlin M Best; Marissa M Mojena; Gordon A Barr; Heath D Schmidt; Akiva S Cohen
Journal:  J Neurotrauma       Date:  2022-01       Impact factor: 4.869

2.  Strategies to avoid a missed diagnosis of co-occurring concussion in post-acute patients having a spinal cord injury.

Authors:  David S Kushner
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

3.  Thrombin as Key Mediator of Seizure Development Following Traumatic Brain Injury.

Authors:  Marina Ben Shimon; Efrat Shavit-Stein; Keren Altman; Chaim G Pick; Nicola Maggio
Journal:  Front Pharmacol       Date:  2020-01-14       Impact factor: 5.810

4.  Mossy cell hypertrophy and synaptic changes in the hilus following mild diffuse traumatic brain injury in pigs.

Authors:  Michael R Grovola; Nicholas Paleologos; Kathryn L Wofford; James P Harris; Kevin D Browne; Victoria Johnson; John E Duda; John A Wolf; D Kacy Cullen
Journal:  J Neuroinflammation       Date:  2020-01-31       Impact factor: 8.322

5.  Assessment of the individual and compounding effects of marginalization factors on injury severity, discharge location, recovery, and employment outcomes at 1 year after traumatic brain injury.

Authors:  Olga Garduño-Ortega; Huihui Li; Michelle Smith; Lanqiu Yao; Judith Wilson; Alejandro Zarate; Tamara Bushnik
Journal:  Front Neurol       Date:  2022-08-26       Impact factor: 4.086

Review 6.  Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity.

Authors:  Adán Pérez-Arredondo; Eduardo Cázares-Ramírez; Paul Carrillo-Mora; Marina Martínez-Vargas; Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Radamés Alemón-Medina; Aristides Sampieri; Luz Navarro; Liliana Carmona-Aparicio
Journal:  Clin Neuropharmacol       Date:  2016 Nov/Dec       Impact factor: 1.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.